In recent years, the development of more effective drugs has provided a better prognosis and an increase in life expectancy for patients at all-stages of cancer. On the other hand, the price for the improving effectiveness of therapies against malignant tumors is the development of severe and potentially life-threatening drug reactions. Among these, cardiac toxic effects have recently gained particular attention. The term cardiotoxicity includes many possible pathological manifestations, but the most frequent is the reduction in cardiac function, potentially leading to heart failure and death. Importantly, the development of cardiac dysfunction may occur immediately after drug administration, or after years. The purpose of this review is to discuss the clinical features of cardiotoxicity, its molecular basis and novel possible strategies to reduce the likelihood of serious cardiac complications.

Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management / Perrino, Cinzia; Schiattarella, Gg; Magliulo, F; Ilardi, F; Carotenuto, G; Gargiulo, G; Serino, F; Ferrone, M; Scudiero, F; Carbone, A; Trimarco, Bruno; Esposito, Giovanni. - In: CURRENT VASCULAR PHARMACOLOGY. - ISSN 1570-1611. - 12:1(2012), pp. 106-116. [10.2174/157016111201140327163302]

Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management.

PERRINO, CINZIA;Schiattarella GG;Magliulo F;Ilardi F;Gargiulo G;Serino F;Ferrone M;TRIMARCO, BRUNO;ESPOSITO, GIOVANNI
2012

Abstract

In recent years, the development of more effective drugs has provided a better prognosis and an increase in life expectancy for patients at all-stages of cancer. On the other hand, the price for the improving effectiveness of therapies against malignant tumors is the development of severe and potentially life-threatening drug reactions. Among these, cardiac toxic effects have recently gained particular attention. The term cardiotoxicity includes many possible pathological manifestations, but the most frequent is the reduction in cardiac function, potentially leading to heart failure and death. Importantly, the development of cardiac dysfunction may occur immediately after drug administration, or after years. The purpose of this review is to discuss the clinical features of cardiotoxicity, its molecular basis and novel possible strategies to reduce the likelihood of serious cardiac complications.
2012
Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management / Perrino, Cinzia; Schiattarella, Gg; Magliulo, F; Ilardi, F; Carotenuto, G; Gargiulo, G; Serino, F; Ferrone, M; Scudiero, F; Carbone, A; Trimarco, Bruno; Esposito, Giovanni. - In: CURRENT VASCULAR PHARMACOLOGY. - ISSN 1570-1611. - 12:1(2012), pp. 106-116. [10.2174/157016111201140327163302]
File in questo prodotto:
File Dimensione Formato  
Cardiac Side Effects of Chemotherapy- State of Art and Strategies for a Correct Management curr vasc pharmacology 2011.pdf

solo utenti autorizzati

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 162.06 kB
Formato Adobe PDF
162.06 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/480769
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 22
social impact